Kitonsa, J.; Serwanga, J.; Cheeseman, H.M.; Abaasa, A.; Lunkuse, J.F.; Ruzagira, E.; Kato, L.; Nambaziira, F.; Oluka, G.K.; Gombe, B.;
et al. Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals. Vaccines 2025, 13, 553.
https://doi.org/10.3390/vaccines13060553
AMA Style
Kitonsa J, Serwanga J, Cheeseman HM, Abaasa A, Lunkuse JF, Ruzagira E, Kato L, Nambaziira F, Oluka GK, Gombe B,
et al. Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals. Vaccines. 2025; 13(6):553.
https://doi.org/10.3390/vaccines13060553
Chicago/Turabian Style
Kitonsa, Jonathan, Jennifer Serwanga, Hannah M. Cheeseman, Andrew Abaasa, Jane Frances Lunkuse, Eugene Ruzagira, Laban Kato, Florence Nambaziira, Gerald Kevin Oluka, Ben Gombe,
and et al. 2025. "Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals" Vaccines 13, no. 6: 553.
https://doi.org/10.3390/vaccines13060553
APA Style
Kitonsa, J., Serwanga, J., Cheeseman, H. M., Abaasa, A., Lunkuse, J. F., Ruzagira, E., Kato, L., Nambaziira, F., Oluka, G. K., Gombe, B., Jackson, S., Ssebwana, J. K., McFarlane, L. R., Joseph, S., Pierce, B. F., Shattock, R. J., & Kaleebu, P.
(2025). Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals. Vaccines, 13(6), 553.
https://doi.org/10.3390/vaccines13060553
